{"product_id":"american-society-of-nephrology-kidney-week-diabetes-management-for-the-nephrology-care-team-2025","title":"American Society of Nephrology Kidney Week Diabetes Management for the Nephrology Care Team 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: nephrologists, endocrinologists, diabetologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe Diabetes Management for the Nephrology Care Team was a full-day Early Program held immediately prior to the main ASN Kidney Week 2025 Annual Meeting. This course was designed to address the “technological revolution” in diabetes care—specifically the rapid adoption of Continuous Glucose Monitoring (CGM) and automated insulin delivery systems—and how these tools must be adapted for patients with Chronic Kidney Disease (CKD) and kidney failure.\u003c\/p\u003e\n\u003cp\u003eHeld in Houston, the program emphasized a “team-based” approach, acknowledging that optimal diabetes management in nephrology requires coordination between nephrologists, pharmacists, and diabetes educators to manage complex new drug classes like GLP-1 receptor agonists and non-steroidal mineralocorticoid receptor antagonists (nsMRAs).\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eWhat You Will Learn\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eThe curriculum focused on the practical implementation of new standards of care. Key learning outcomes included:\u003c\/h3\u003e\n\u003cp\u003eCGM Mastery: How to interpret Ambulatory Glucose Profiles (AGP) and “Time in Range” specifically for patients on dialysis, where traditional A1c metrics are often unreliable.\u003c\/p\u003e\n\u003cp\u003eInsulin Automation: Understanding the mechanics of “Closed-Loop” insulin pumps (Automated Insulin Delivery) and how to troubleshoot them in a hospital or dialysis setting.\u003c\/p\u003e\n\u003cp\u003eBiomarker Nuances: Beyond A1c—using glycated albumin and fructosamine to assess glycemic control in patients with anemia or high erythrocyte turnover.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eEvent Details\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEvent: Diabetes Management for the Nephrology Care Team: New Technology and New Drugs\u003c\/p\u003e\n\u003cp\u003eDate: November 5, 2025 (Wednesday)\u003c\/p\u003e\n\u003cp\u003eLocation: Room 360A, George R. Brown Convention Center, Houston, Texas, USA\u003c\/p\u003e\n\u003cp\u003eChairs: Ian de Boer, MD, MS \u0026amp; Joshua J. Neumiller, PharmD.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eWho Should Attend\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNephrologists: Who are increasingly becoming the “primary” metabolic physician for their CKD patients.\u003c\/p\u003e\n\u003cp\u003eClinical Pharmacists: Managing complex medication reconciliations and dosage adjustments for renal function.\u003c\/p\u003e\n\u003cp\u003eDiabetes Educators (CDCES): Working within renal clinics.\u003c\/p\u003e\n\u003cp\u003eDialysis Nurses: Who need to understand the wearable devices their patients are bringing into the dialysis unit.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eWhy Attend (or Watch)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e“The Good, The Bad, and The Ugly”: A dedicated session on the limitations of current biomarkers in dialysis patients, helping clinicians avoid over-treating “false high” A1cs or missing “false lows.”\u003c\/p\u003e\n\u003cp\u003eTransplant Focus: Specific modules on managing Post-Transplant Diabetes Mellitus (PTDM) using the newer incretin-based therapies that were previously avoided in this population.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eThe agenda included focused clinical modules:\u003c\/h3\u003e\n\u003ch3\u003eDiagnostics \u0026amp; Technology:\u003c\/h3\u003e\n\u003cp\u003eNot Always Typical: Updates on atypical diabetes classification.\u003c\/p\u003e\n\u003cp\u003ePushing Back the Curtain: CGM use specifically in patients on hemodialysis.\u003c\/p\u003e\n\u003ch3\u003eTherapeutics:\u003c\/h3\u003e\n\u003cp\u003eIncretin Mimetics: Practical guide to using GLP-1s in the nephrology clinic.\u003c\/p\u003e\n\u003cp\u003ePumps, Pens, and New Insulins: What the nephrologist needs to know about the latest delivery devices.\u003c\/p\u003e\n\u003ch3\u003eHolistic Care:\u003c\/h3\u003e\n\u003cp\u003eCombination Therapies: Synergistic use of RAS inhibitors, SGLT2i, and nsMRAs for maximum cardio-renal protection.\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405800329412,"sku":null,"price":130.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Society-of-Nephrology-Kidney-Week-Diabetes-Management-for-the-Nephrology-Care-Team-2025.jpg?v=1784216352","url":"https:\/\/medicalcoursespro.com\/products\/american-society-of-nephrology-kidney-week-diabetes-management-for-the-nephrology-care-team-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}